Acerus Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Acerus Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 481% to -$4,133,000. Profit margin reached 858%. Total operating expenses were $27,724,000.
Profit Margin
| 2012 | 0 | -28.02M | |
|---|---|---|---|
| 2013 | 0 | -31.95M | |
| 2014 | 4.31M | -22.64M | -525.04% |
| 2015 | 16.91M | -9.03M | -53.39% |
| 2016 | 24.48M | 11.11M | 45.41% |
| 2017 | 6.44M | -8.71M | -135.23% |
| 2018 | 7.37M | -18.78M | -254.66% |
| 2019 | 3.76M | -16.12M | -428.05% |
| 2020 | 1.08M | -24.42M | -2251.06% |
| 2021 | -4.13M | -35.45M | 857.88% |
ASP.TO Income Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | -4.13M | 1.08M | 3.76M | 7.37M | 6.44M | 24.48M | 16.91M | 4.31M | 0 | 0 |
Cost of revenue | 1.11M | 2.01M | 2.19M | 10.32M | 3.26M | 4.45M | 5.10M | 9.18M | 0 | 0 |
Gross profit | -5.25M | -929K | 1.56M | -2.94M | 3.18M | 20.03M | 11.80M | -4.87M | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 6.56M | 2.52M | 2.82M | 2.39M | 2.16M | 1.59M | 2.87M | 9.05M | 22.68M | 16.52M |
Selling and marketing | 13.94M | 12.27M | 4.78M | 2.24M | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 27.72M | 20.32M | 13.06M | 10.95M | 10.13M | 7.07M | 8.65M | 14.51M | 32.57M | 27.41M |
Operating income | -32.17M | -21.25M | -11.5M | -13.90M | -6.95M | 12.95M | 3.15M | -19.38M | -32.57M | -27.41M |
Other income (expenses), net | -1.63M | -3.16M | -4.62M | -4.85M | -1.71M | -1.54M | -12.57M | -3.25M | 302.36K | -715.34K |
Income before tax | -33.81M | -24.42M | -16.12M | -18.75M | -8.66M | 11.41M | -9.42M | -22.64M | -32.27M | -28.13M |
Income tax expense | 1.63M | -1.61M | -2.93M | 29K | 47K | 300K | -390K | -1.62M | -320K | -110.98K |
Net income | -35.45M | -24.42M | -16.12M | -18.78M | -8.71M | 11.11M | -9.03M | -22.64M | -31.95M | -28.02M |
Earnings per share | ||||||||||
Basic EPS | -4.61 | -16.7 | -11.03 | -14.59 | -7.13 | 9.27 | -7.84 | -22.37 | -42.73 | -56.38 |
Diluted EPS | -4.61 | -16.7 | -11.03 | -14.59 | -7.13 | 9.21 | -7.84 | -22.37 | -42.73 | -56.38 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |